beta-lactams has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fayne, D; Greene, LM; Malebari, AM; Meegan, MJ; Nathwani, SM; O'Boyle, NM; Twamley, B; Wang, S; Zisterer, DM | 1 |
| Aranda, MT; Cuevas, C; Francesch, A; García-López, MT; González-Muñiz, R; Pérez-Faginas, P | 1 |
2 other study(ies) available for beta-lactams and Colonic Neoplasms
| Article | Year |
|---|---|
β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; beta-Lactams; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; Glucuronates; HT29 Cells; Humans; Inactivation, Metabolic; Stilbenes; Structure-Activity Relationship | 2017 |
Optically active 1,3,4,4-tetrasubstituted β-lactams: synthesis and evaluation as tumor cell growth inhibitors.
Topics: Antineoplastic Agents; beta-Lactams; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Colonic Neoplasms; Humans; Stereoisomerism; Structure-Activity Relationship | 2011 |